A randomised control trial of BIC/F/TAF vs DRV/c/F/TAF in context of HIV test-and-treat, BicTnT

Background Head-to-head data for bictegravir/emtricitabine/tenofovir alafenamide (BIC/F/TAF; B) and darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DRV/c/F/TAF; D) are lacking in the context of rapid antiretroviral therapy (ART) initiation. This study, BIC-T&T, evaluates the efficacy a...

Full description

Bibliographic Details

Published in:	HIV Research & Clinical Practice
Main Authors:	Gary Whitlock, Sarah Fidler, Amanda Clarke, Sujin Kang, Arnold Xhikola, Ana Milinkovic, Alfredo Soler-Carracedo, Merle Henderson, Tanya Adams, Ishrat Jahan, Akif Khawaja, Graham Taylor, Marta Boffito
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Subjects:	drv/c/f/taf bic/ftc/taf hiv infection rapid art strategy test-and-treat
Online Access:	http://dx.doi.org/10.1080/25787489.2024.2400453